Novo Nordisk | L'Utile Operativo



Operating Profit Cambiamento Data
ANI Pharmaceuticals USD 26.19M 30.57M 2025-03
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bausch Health Companies USD 276M 332M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novo Nordisk 38.79B 4.97B 2025-03
Novo Nordisk DKK 33.82B 7.89B 2024-09
Pacira USD 1.99M 22.71M 2025-03
Perrigo USD 112.7M 37.4M 2024-12
Prestige Brands USD 88.43M 3.53M 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Zoetis USD 810M 78M 2025-03



Novo Nordisk L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.